+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Catheter-Related Bloodstream Infection Market Report 2025

  • PDF Icon

    Report

  • 200 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 5995021
This Catheter-Related Bloodstream Infection market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The catheter-related bloodstream infection market size has grown strongly in recent years. It will grow from $1.53 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the rising incidence of chronic diseases, increased awareness and education, rise in hospital-acquired infections, the growing elderly population, and enhanced infection control programs in hospitals and healthcare settings.

The catheter-related bloodstream infection market size is expected to see strong growth in the next few years. It will grow to $2.05 billion in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing healthcare-associated infections (hais), rising awareness and training, enhanced awareness and training programs on infection control practices, expansion of healthcare infrastructure, increase in geriatric population, supportive government policies and initiatives. Major trends in the forecast period include biomaterial innovations, smart catheter technology, the development of more effective catheter lock solutions with advanced antimicrobial properties, innovations in sterilization processes for catheters, and automated flushing systems.

The increasing incidence of hospital-acquired infections is anticipated to drive growth in the market for catheter-related bloodstream infections in the future. Hospital-acquired infections (HAIs) are infections that patients contract while undergoing treatment for other conditions in healthcare settings, typically emerging 48 hours or more after admission. Factors contributing to the rise in hospital-acquired infections include antimicrobial resistance, inadequate infection control protocols, and patient vulnerability. Catheter-related bloodstream infections are particularly problematic within HAIs due to the invasive nature of catheters and their potential for microbial colonization, posing risks to patients with indwelling catheters. For example, the National Library of Medicine reported in January 2023 that the global healthcare-associated infection (HAI) rate was 0.14%, with an annual increase of 0.06%. Hence, the escalating prevalence of hospital-acquired infections is set to propel growth in the catheter-related bloodstream infection market.

Leading companies in the catheter-related bloodstream infection market are focusing on developing innovative solutions such as catheter lock therapies to enhance infection prevention and improve patient outcomes. A catheter lock solution involves instilling a liquid into a catheter to prevent infections and maintain catheter patency between uses. For instance, in November 2023, CorMedix Inc., a US-based biopharmaceutical firm specializing in therapeutic products, received FDA approval for DefenCath (taurolidine and heparin) catheter lock solution. This solution is tailored for adult patients with kidney failure undergoing chronic hemodialysis through central venous catheters (CVCs), combining heparin for anticoagulation with taurolidine's broad-spectrum antimicrobial properties to reduce catheter-related bloodstream infections (CRBSIs).

In April 2022, CEMMA Medical Company Limited, based in Taiwan, partnered with LipoCoat BV to develop a coated central venous catheter (CVC) aimed at sustainable infection control. This collaboration leverages CEMMA's expertise in catheter technology and LipoCoat's bio-inspired coating technology, aiming to deliver an advanced CVC solution to combat the global challenge of healthcare-associated infections. LipoCoat BV, headquartered in the Netherlands, specializes in bio-inspired coating technologies.

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC.

North America was the largest region in the catheter-related bloodstream infection market in 2024. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the catheter-related bloodstream infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Catheter-related bloodstream infection (CRBSI) is a serious healthcare-associated infection caused by bacteria or fungi entering the bloodstream through a catheter - a tube used to administer medications or nutrients directly into a vein. This condition can lead to sepsis and other severe complications, emphasizing the critical need for prompt diagnosis and treatment.

The primary treatments for CRBSI include antibiotic lock therapy and antimicrobial agents. Antibiotic lock therapy involves infusing a concentrated antibiotic solution into the catheter lumen, where it remains for an extended period to prevent or eliminate catheter-related infections locally, without systemic administration. This approach is frequently employed in patients with central venous catheters to manage and prevent CRBSI. Common sources of infection and causative agents include Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), Candida species, Pseudomonas aeruginosa, among others. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacies.

The catheter-related bloodstream infection research report is one of a series of new reports that provides catheter-related bloodstream infection market statistics, including the catheter-related bloodstream infection industry's global market size, regional shares, competitors with a catheter-related bloodstream infection market share, detailed catheter-related bloodstream infection market segments, market trends and opportunities, and any further data you may need to thrive in the catheter-related bloodstream infection industry. This catheter-related bloodstream infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The catheter-related bloodstream infection market consists of revenues earned by entities by providing services such as blood culture testing, catheter flushing and maintenance, aseptic catheter insertion, hand hygiene training, and compliance monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The catheter-related bloodstream infection market also includes sales of catheters, catheter insertion kits, catheter maintenance equipment, monitoring and diagnostic devices, and infection control equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Catheter-Related Bloodstream Infection Market Characteristics3. Catheter-Related Bloodstream Infection Market Trends and Strategies4. Catheter-Related Bloodstream Infection Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
5. Global Catheter-Related Bloodstream Infection Growth Analysis and Strategic Analysis Framework
5.1. Global Catheter-Related Bloodstream Infection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis of End Use Industries
5.3. Global Catheter-Related Bloodstream Infection Market Growth Rate Analysis
5.4. Global Catheter-Related Bloodstream Infection Historic Market Size and Growth, 2019-2024, Value ($ Billion)
5.5. Global Catheter-Related Bloodstream Infection Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Billion)
5.6. Global Catheter-Related Bloodstream Infection Total Addressable Market (TAM)
6. Catheter-Related Bloodstream Infection Market Segmentation
6.1. Global Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibiotic Lock Therapy
  • Anti-Microbial Agents
6.2. Global Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Staphylococcus Aureus
  • Acinetobacter Baumannii
  • Escherichia Coli (E. Coli)
  • Klebsiella Pneumoniae (K. Pneuminiae)
  • Candida Species (Candida Sp.)
  • Pseudomonas Aeruginosa (P. Aeruginsa)
  • Other Source of Infection or Causative Agents
6.3. Global Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
6.4. Global Catheter-Related Bloodstream Infection Market, Sub-Segmentation of Antibiotic Lock Therapy, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter Lock Solutions (Antibiotic-based)
  • Combination Antibiotic Lock Therapy
6.5. Global Catheter-Related Bloodstream Infection Market, Sub-Segmentation of Anti-Microbial Agents, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibiotics
  • Antifungal Agents
  • Antiseptic Agents
7. Catheter-Related Bloodstream Infection Market Regional and Country Analysis
7.1. Global Catheter-Related Bloodstream Infection Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Catheter-Related Bloodstream Infection Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Catheter-Related Bloodstream Infection Market
8.1. Asia-Pacific Catheter-Related Bloodstream Infection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Catheter-Related Bloodstream Infection Market
9.1. China Catheter-Related Bloodstream Infection Market Overview
9.2. China Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Catheter-Related Bloodstream Infection Market
10.1. India Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Catheter-Related Bloodstream Infection Market
11.1. Japan Catheter-Related Bloodstream Infection Market Overview
11.2. Japan Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Catheter-Related Bloodstream Infection Market
12.1. Australia Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Catheter-Related Bloodstream Infection Market
13.1. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Catheter-Related Bloodstream Infection Market
14.1. South Korea Catheter-Related Bloodstream Infection Market Overview
14.2. South Korea Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Catheter-Related Bloodstream Infection Market
15.1. Western Europe Catheter-Related Bloodstream Infection Market Overview
15.2. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Catheter-Related Bloodstream Infection Market
16.1. UK Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Catheter-Related Bloodstream Infection Market
17.1. Germany Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Catheter-Related Bloodstream Infection Market
18.1. France Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Catheter-Related Bloodstream Infection Market
19.1. Italy Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Catheter-Related Bloodstream Infection Market
20.1. Spain Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Catheter-Related Bloodstream Infection Market
21.1. Eastern Europe Catheter-Related Bloodstream Infection Market Overview
21.2. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Catheter-Related Bloodstream Infection Market
22.1. Russia Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Catheter-Related Bloodstream Infection Market
23.1. North America Catheter-Related Bloodstream Infection Market Overview
23.2. North America Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Catheter-Related Bloodstream Infection Market
24.1. USA Catheter-Related Bloodstream Infection Market Overview
24.2. USA Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Catheter-Related Bloodstream Infection Market
25.1. Canada Catheter-Related Bloodstream Infection Market Overview
25.2. Canada Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Catheter-Related Bloodstream Infection Market
26.1. South America Catheter-Related Bloodstream Infection Market Overview
26.2. South America Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Catheter-Related Bloodstream Infection Market
27.1. Brazil Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Catheter-Related Bloodstream Infection Market
28.1. Middle East Catheter-Related Bloodstream Infection Market Overview
28.2. Middle East Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Catheter-Related Bloodstream Infection Market
29.1. Africa Catheter-Related Bloodstream Infection Market Overview
29.2. Africa Catheter-Related Bloodstream Infection Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Catheter-Related Bloodstream Infection Market, Segmentation by Source of Infection or Causative Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Catheter-Related Bloodstream Infection Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Catheter-Related Bloodstream Infection Market Competitive Landscape and Company Profiles
30.1. Catheter-Related Bloodstream Infection Market Competitive Landscape
30.2. Catheter-Related Bloodstream Infection Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
31. Catheter-Related Bloodstream Infection Market Other Major and Innovative Companies
31.1. Fresenius Medical Care AG & Co. KGaA
31.2. Becton Dickinson and Company
31.3. Viatris Inc.
31.4. B. Braun Medical Inc.
31.5. Aurobindo Pharma Limited
31.6. Lupin Ltd.
31.7. Xellia Pharmaceuticals Ltd.
31.8. SteriMax Inc.
31.9. Geistlich Pharma AG
31.10. Bactiguard AB
31.11. Hetero Healthcare Ltd.
31.12. TauroPharm GmbH
31.13. Advacare Pharma
31.14. Citus Pharmaceuticals Inc.
31.15. CorMedix Inc.
32. Global Catheter-Related Bloodstream Infection Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Catheter-Related Bloodstream Infection Market34. Recent Developments in the Catheter-Related Bloodstream Infection Market
35. Catheter-Related Bloodstream Infection Market High Potential Countries, Segments and Strategies
35.1 Catheter-Related Bloodstream Infection Market in 2029 - Countries Offering Most New Opportunities
35.2 Catheter-Related Bloodstream Infection Market in 2029 - Segments Offering Most New Opportunities
35.3 Catheter-Related Bloodstream Infection Market in 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Catheter-Related Bloodstream Infection Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on catheter-related bloodstream infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for catheter-related bloodstream infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The catheter-related bloodstream infection market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Treatment: Antibiotic Lock Therapy; Anti-Microbial Agents
2) By Source of Infection or Causative Agents: Staphylococcus Aureus; Acinetobacter Baumannii; Escherichia Coli (E. Coli); Klebsiella Pneumoniae (K. Pneumonia); Candida Species (Candida Sp.); Pseudomonas Aeruginosa (P. Aeruginosa); Other Source of Infection or Causative Agents
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based); Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics; Antifungal Agents; Antiseptic Agents

Key Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Novartis AG; 3M Company; Eli Lilly and Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

The major companies featured in this Catheter-Related Bloodstream Infection market report include:
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • 3M Company
  • Eli Lilly and Company
  • Fresenius Medical Care AG & Co. KGaA
  • Becton Dickinson and Company
  • Viatris Inc.
  • B. Braun Medical Inc.
  • Aurobindo Pharma Limited
  • Lupin Ltd.
  • Xellia Pharmaceuticals Ltd.
  • SteriMax Inc.
  • Geistlich Pharma AG
  • Bactiguard AB
  • Hetero Healthcare Ltd.
  • TauroPharm GmbH
  • Advacare Pharma
  • Citus Pharmaceuticals Inc.
  • CorMedix Inc.
  • JoinHub Pharma LLP
  • IntegraDose Compounding Services LLC

Table Information